Alaskan Malamute
Alaskanmalamuutti
Alaskan Malamute
FCI Group
Spitz and Primitive Types
AKC Group
Working
TKC Group
Working
Country of Origin
US
Alaskan Malamute
Health Testing Requirements by Country
Skeletal and Muscular
UK
Endocrine and Pancreas
FI
Ataxia, Locomotor, and Epilepsy
Eye Conditions and Blindness
Other Genetic Testing
SE
Genetic Material and Diversity
Test Relevances
2,8-Dihydroxyadenine Urinary Stones
Some Relevance
Achromatopsia (Cone Degeneration, Hemeralopia), AMAL
Some Relevance
Polyneuropathy - NDRG1 Type (AMPN)
Some Relevance
Coat Colour Dilution, dilution, MLPH-related
No Evidence
Degenerative Myelopathy
No Evidence
Hair, Long
No Evidence
2,8-Dihydroxyadenine Urinary Stones
Some Relevance
Achromatopsia (Cone Degeneration, Hemeralopia), AMAL
Some Relevance
Polyneuropathy - NDRG1 Type (AMPN)
Some Relevance
Coat Colour Dilution, dilution, MLPH-related
No Evidence
Degenerative Myelopathy
No Evidence
Both clinically rare and of complex inheritance. Test is considered poorly correlated with risk for development of DM, and recommendations are to not use the test for breed-wide breeding strategies. While the SOD 1 variant may be commonly found across many breeds, there are few clinical cases observed and confirmed, and in many cases DM has never been observed in the breeds.
Hair, Long
No Evidence
Hair length testing has the potential relevance to any dog, but test usage is most often applied to those breeds with a heritage of these traits.
- Updated
- Add Breed